Neuroprotective effects of p62(SQSTM1)-engineered lactic acid bacteria in Alzheimer's disease: a pre-clinical study.
Cecarini V, Bonfili L, Gogoi O, Lawrence S, Venanzi FM, Azevedo V, Mancha-Agresti P, Drumond MM, Rossi G, Berardi S, Galosi L, Cuccioloni M, Angeletti M, Suchodolski JS, Pilla R, Lidbury JA, Eleuteri AM.
Cecarini V, et al.
Aging (Albany NY). 2020 Aug 28;12(16):15995-16020. doi: 10.18632/aging.103900. Epub 2020 Aug 28.
Aging (Albany NY). 2020.
PMID: 32855357
Free PMC article.